NIH Slated for 7 percent Budget Cut
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020. The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors. The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - February 18, 2020 Category: Biology Authors: AIBS Source Type: news

10 African Americans Who Have Shaped  Public Health
By Casey Bishopp, Communications officer, IntraHealth International ; Sabra Farquharson, Business development officer, IntraHealth InternationalFebruary 18, 2020We’re celebrating the legacies of ten African Americans in public health this month—shining a light on the invaluable contributions made by these scholars and health workers. According to themost recent report form the Health Resources and Services Administration, African Americans make up 11.6% of the US health workforce, and throughout American history have made invaluable contributions to greater public health in fields s...
Source: IntraHealth International - February 17, 2020 Category: International Medicine & Public Health Authors: cbishopp Source Type: news

HPV vaccine hesitancy in Japan could result in 5,000 additional death
(Hokkaido University) The precipitous drop in HPV vaccination rates after suspension of proactive recommendations by the government in 2013 could result in an additional 25,000 cervical cancer cases and more than 5,000 additional deaths among females born between 1994 to 2007 in Japan. However, swift action by the government could mitigate much of this damage according to a study in Lancet Public Health. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2020 Category: Cancer & Oncology Source Type: news

Japan's Halt of Regular HPV Vaccine to Cause Thousands of Cancer Deaths - Study Japan's Halt of Regular HPV Vaccine to Cause Thousands of Cancer Deaths - Study
A decision by Japan to stop recommending adolescent girls receive a HPV vaccination will likely result in almost 11,000 deaths from cervical cancer if it is not reversed, according to a study published on Monday.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 11, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Personalized cancer vaccines
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome. Firstly, since tumor mutations are unique to each patient, cancer cell antigens must be targeted extremely precisely, which is very hard to achieve. (Source: World Pharma News)
Source: World Pharma News - February 11, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Japan's halt of regular HPV vaccine to cause thousands of cancer deaths: study
A decision by Japan to stop recommending adolescent girls receive a HPV vaccination will likely result in almost 11,000 deaths from cervical cancer if it is not reversed, according to a study in a prestigious medical journal. (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Personalized cancer vaccines
(Ecole Polytechnique F é d é rale de Lausanne) The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials. EPFL researchers are currently working on an alternative. They have developed a platform that allows a cancer vaccine to be delivered to a precise location and stimulate the immune system in a safe way -- thereby overcoming one of the two obstacles to creating an effective vaccine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 11, 2020 Category: International Medicine & Public Health Source Type: news

Janssen Announces Submission to U.S. FDA for New DARZALEX ® (Daratumumab)-Based Combination Regimen for Patients with Relapsed/Refractory Multiple Myeloma
RARITAN, NJ, February 10, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of DARZALEX® (daratumumab) in combination with Kyprolis® (carfilzomib) and dexamethasone (DKd) for relapsed/refractory multiple myeloma. The sBLA is supported by results from the Phase 3 CANDOR study, which compared treatment with DKd to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who relapsed after one to three prior lines of therapy. “W...
Source: Johnson and Johnson - February 10, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

One HPV Vaccine Dose May Be As Effective As Multiple, Study Finds
BOSTON (CBS) — It is currently recommended that boys and girls under age 15 get two doses of the human papillomavirus (HPV) vaccine but a new study published in the journal Cancer finds that just one dose may be as effective. HPV is the most common sexually transmitted infection and certain strains of the virus are associated with cervical cancer in women. Researchers at the University of Texas looked at more than 130,000 females and found that one dose of the HPV vaccine was as effective as multiple doses for preventing cervical changes that often lead to cervical cancer. The hope is that if only one dose is require...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HPV vaccine Source Type: news

One Dose of HPV Vaccine May Protect Against Cervical Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 10, 2020 Category: Cancer & Oncology Tags: Infections, Oncology, Pediatrics, Reproductive Medicine, News, Source Type: news

One Dose of HPV Vaccine May Protect Against Cervical Cancer
MONDAY, Feb. 10, 2020 -- A single dose of the human papillomavirus (HPV) vaccine works as well as multiple doses to protect older teen girls against preinvasive cervical disease, which can develop into cervical cancer, researchers say. For the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 10, 2020 Category: General Medicine Source Type: news

Single HPV vaccine dose may be effective against cervical cancer
(Wiley) New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

Cervical cancer elimination possible within two decades in the US
(Harvard T.H. Chan School of Public Health) At current levels of screening and HPV vaccination, cervical cancer incidence in the US is projected to fall below the threshold of elimination by 2038-2046. Scaling up screening coverage to 90% could expedite elimination timing by 10-13 years and avert an average of 1,400-2,088 additional cases per year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

Cervical cancer: Single jab could slash risk of deadly disease
CERVICAL cancer could be prevented with a single jab, researchers have revealed. One dose of the HPV vaccine can slash the risk of developing the disease by more than a third - and a single treatment has been shown to be more effective than having two or three injections. (Source: Daily Express - Health)
Source: Daily Express - Health - February 10, 2020 Category: Consumer Health News Source Type: news

Cancer-causing HPV can hit you even if you had the vaccination
Jessica Donald, from Birmingham, thought she'd get the all-clear after a cervical cancer screening test at her GP - only to be told she'd tested positive for human papillomavirus. (Pictured, stock image.) (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2020 Category: Consumer Health News Source Type: news

Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Vaccine Was Most Effective in Stage IV Melanoma; 73 Percent of Patients Who Completed the Primary Vaccine Series Were Disease-Free at 24 Months Results Reflect Synergistic Anti-Tumor Effect When Vaccine is Combined with Checkpoint Inhibitors AUSTIN, ... Biopharmaceuticals, Oncology Elios Therapeutics, cancer vaccine, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2020 Category: Pharmaceuticals Source Type: news

UN Health Agency Predicts 80 Percent Rise in Cancer Burden Among Poorest Countries
Many specialist doctors and nurses in Africa are migrating to greener pastures, leaving cancer patients with few options. Credit: Jeffrey Moyo/IPSBy External SourceLONDON, Feb 7 2020 (IPS) Low- and middle-income countries could see an 80 per cent rise in cancer over the next 20 years if treatment and prevention services are not stepped up, according to the latest World Cancer Report. The report, compiled by the World Health Organization (WHO), warns that cancer prevention is taking a back seat in poor countries, as their health systems tackle such immediate problems as infectious diseases, child health and nutrition. The r...
Source: IPS Inter Press Service - Health - February 7, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs Source Type: news

Kenya: Doctors Vouch for Vaccination to Stave Off Cervical Cancer
[Capital FM] Nairobi -Detecting and removing abnormal cervical cells can prevent cervical cancer. Screening is an effective method for detecting abnormal cells in the cervix. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 7, 2020 Category: African Health Source Type: news

Cancer vaccine could boost the effectiveness of immunotherapy
(Institute of Cancer Research) Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2020 Category: Cancer & Oncology Source Type: news

Hope for an HIV vaccine not lost after one drug proves ineffective
An HIV vaccine studied at the Fred Hutchinson Cancer Research Center will no longer be pursued after an independent study revealed the drug is ineffective at preventing the virus. “We’re disappointed in this one,” said Larry Corey, former Fred Hutch president and founder and principal investigator of the HIV Vaccine Trials Network, which was investigating the drug and is headquartered at Fred Hutch. “It’s one of those things you have to pick yourself up and move o n.” The National Institute… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2020 Category: Pharmaceuticals Authors: Megan Campbell Source Type: news

Hope for an HIV vaccine not lost after one drug proves ineffective
An HIV vaccine studied at the Fred Hutchinson Cancer Research Center will no longer be pursued after an independent study revealed the drug is ineffective at preventing the virus. “We’re disappointed in this one,” said Larry Corey, former Fred Hutch president and founder and principal investigator of the HIV Vaccine Trials Network, which was investigating the drug and is headquartered at Fred Hutch. “It’s one of those things you have to pick yourself up and move o n.” The National Institute… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2020 Category: Biotechnology Authors: Megan Campbell Source Type: news

New vaccine hope as viruses are discovered in one in eight tumours
Scientists at the University of East Anglia who analysed more than 2,600 tumour samples from 38 types of cancer found viruses in 13 per cent of them. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2020 Category: Consumer Health News Source Type: news

Merck to spin off women's health and biosimilar drugs, focus on Keytruda
Merck& Co Inc said on Wednesday it intends to spin off its women's health, biosimilar drugs and older products into a new publicly traded company, a move that will allow the company to focus on growth drivers like cancer drug Keytruda and vaccines. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Whether HPV Vaccination Will Prevent Cervical Cancer Unclear
Review highlights limitations of trial design; additional research needed to address uncertainties (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, Pathology, Pediatrics, Pharmacy, Journal, Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cervical Cancer Could All But Disappear in North America by 2040
MONDAY, Feb. 3, 2020 -- Vaccination and screening could nearly wipe out cervical cancer in North America in the next 20 years and rid the world of the disease within the next century, researchers say. In a new study, the researchers assessed the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news

Whether HPV Vaccination Will Prevent Cervical Cancer Unclear
MONDAY, Feb. 3, 2020 -- Methodological problems and study limitations for trials of the human papillomavirus (HPV) vaccine create uncertainty about its ability to prevent cervical cancer in the long term, according to a review published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2020 Category: Pharmaceuticals Source Type: news

Poliovirus therapy shows potential as cancer vaccine in lab studies
A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for pediatric brain tumors when used as part of a cancer vaccine. In preclinical studies using mice and human cancer cells, an injection of the modified poliovirus vector instigated an immune response that homed in on mutated cancer cells that predominate in diffuse midline glioma (DMG) tumors. The cancer strikes children and is universally deadly. (Source: World Pharma News)
Source: World Pharma News - January 30, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Poliovirus therapy shows potential as cancer vaccine in lab studies
(Duke University Medical Center) A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for pediatric brain tumors when used as part of a cancer vaccine. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 30, 2020 Category: Biology Source Type: news

National Vaccination Program Leads To Marked Reduction In HPV Infections
When Marcia Cross linked her anal cancer to HPV infection, it raised yet another red flag that HPV can affect the gastrointestinal tract, not just the female reproductive tract. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 28, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
Source: Asbestos and Mesothelioma News - January 27, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015.
CONCLUSIONS:The authors found relatively higher and increasing incidence rate of OPC in Florida and lower rate of HPV vaccination among adolescents in Florida than in the nation overall.PRACTICAL IMPLICATIONS:The trends illustrated may stimulate policy changes to increase HPV vaccination for children and enhance the understanding of its benefits. (Source: Dental Technology Blog)
Source: Dental Technology Blog - January 23, 2020 Category: Dentistry Source Type: news

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Chimeric antigen receptor (CAR)–T cells have shown efficacy in patients with B cell malignancies. Yet, their application for solid tumors has challenges that include limited cancer-specific targets and nonpersistence of adoptively transferred CAR-T cells. Here, we introduce the developmentally regulated tight junction protein claudin 6 (CLDN6) as a CAR target in solid tumors and a strategy to overcome inefficient CAR-T cell stimulation in vivo. We demonstrate that a nanoparticulate RNA vaccine, designed for body-wide delivery of the CAR antigen into lymphoid compartments, stimulates adoptively transferred CAR-T cells...
Source: ScienceNOW - January 23, 2020 Category: Science Authors: Reinhard, K., Rengstl, B., Oehm, P., Michel, K., Billmeier, A., Hayduk, N., Klein, O., Kuna, K., Ouchan, Y., Wöll, S., Christ, E., Weber, D., Suchan, M., Bukur, T., Birtel, M., Jahndel, V., Mroz, K., Hobohm, K., Kranz, L., Diken, M., Kühlc Tags: Immunology reports Source Type: news

HPV infections very low due to vaccine coverage
Hopes for cervical cancer to be eliminated Related items fromOnMedica Decision to give boys HPV jab will save thousands of lives NHS England strips Capita of cervical screening contract Doubts raised about effectiveness of HPV vaccines HPV programme linked to dramatic fall in cervical disease JCVI recommends universal HPV vaccination (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 22, 2020 Category: UK Health Source Type: news

HPV vaccine minimises impact of cancer-causing infections
Cancer-causing HPV16 and 18 infections are now extremely uncommon in young sexually active women in England, following the introduction of HPV (human papillomavirus) vaccination in 2008. (Source: NHS Networks)
Source: NHS Networks - January 22, 2020 Category: UK Health Source Type: news

HPV infections drop sharply but experts warn vaccination may not stop cervical cancer
HPV infection has dropped sharply among sexually active young women in England since a national vaccination programme began - but researchers say it is 'uncertain' whether the jabs prevent cervical cancer. (Source: GP Online News)
Source: GP Online News - January 21, 2020 Category: Primary Care Tags: Clinical News Source Type: news

Doubts raised about effectiveness of HPV vaccines
(SAGE) A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness. The analysis, published by the Journal of the Royal Society of Medicine, assessed 12 published Phase 2 and 3 randomized controlled efficacy trials of the HPV vaccines Cervarix and Gardasil. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 21, 2020 Category: Cancer & Oncology Source Type: news

Cervical cancer could be on its way to extinction thanks to improved testing and vaccination
A new detection method rolled out last month looks for traces of the human papillomavirus (HPV), which cause nearly all cervical tumours. (Source: the Mail online | Health)
Source: the Mail online | Health - January 20, 2020 Category: Consumer Health News Source Type: news

Medical News Today: Using salt to fight cancer
A recent study in mice finds that salt nanoparticles can kill cancer cells. The results also show that the dead cells act as a cancer vaccine. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 16, 2020 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Charlestown Cancer Survivor Hopes Story Inspires Others To Get Screened
BOSTON (CBS) – January is cervical cancer awareness month and Kate Weissman of Charlestown is hoping her story will inspire women to get potentially life-saving screening tests. Four years ago, she heard the words that everyone dreads – “You have cancer.” “It was devastating,” she recalls thinking of that moment alone in her apartment. “I just said to myself, I’m 30 and I’m going to die.” Weissman endured months of grueling treatment. Doctors initially thought they got it all, but the cancer turned up in her lymph nodes. So she had to go back for more treatment, a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 14, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated CBSN Boston Syndicated Local cervical cancer Source Type: news

‘Normal’ Human Body Temperature Has Changed in the Last Century
Whether you have a stomachache, a wrist sprain or a chronic disease, one of the first things doctors and nurses will do at an appointment is take your temperature. A normal temperature means your body is humming along the way it should. A higher temperature means you have a fever, and shows your body could be fighting an infection. And since 1871, “normal” has meant 98.6°F (37°C). That number was determined by a German physician, based on millions of readings from 25,000 German patients, taken by sticking thermometers under their arms. When doctors in the U.S. and Europe repeated the experiment in local...
Source: TIME: Health - January 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized fever health inflammation Research Source Type: news

Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking ...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news

A solid vaccine for liquid tumors
(Wyss Institute for Biologically Inspired Engineering at Harvard) Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years. Chemotherapy has been the standard treatment for over 40 years, and while it often causes the cancer to go into remission, nearly half of patients experience disease relapse. Scientists at the Wyss Institute and Harvard SEAS have developed an injectable, biomaterial-based vaccine that, when combined with standard chemotherapy, caused complete and lasting recovery from and immunity against AML in mice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2020 Category: Cancer & Oncology Source Type: news

Medical News Today: Flu vaccines may shrink tumors and boost cancer treatment
According to recent experiments in mouse models, a flu shot may effectively shrink cancer tumors and boost the effectiveness of immunotherapy. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 11, 2020 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Immunotherapy for CRC: Current and Novel Approaches Immunotherapy for CRC: Current and Novel Approaches
Review the latest on targeted mAbs, checkpoint inhibitors, adoptive T-cell therapies, and vaccine therapies for colorectal cancer.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 10, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Correcting vaccine misinformation is a difficult process, study shows
(University of North Carolina at Chapel Hill) Researchers found that vaccine misinformation in Danish media outlets from 2013-2016 led to HPV vaccinations dropping by 50.4%. An information campaign geared toward concerned parents helped increase vaccine uptake again, but uptake is still below the level before misinformation began, showing how difficult it is to undo the damages misinformation causes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 7, 2020 Category: Cancer & Oncology Source Type: news

Can the flu shot help fight cancer?
(Rush University Medical Center) Physicians and scientists at Rush University Medical Center have found that injecting tumors with influenza vaccines, including some FDA-approved seasonal flu shots, turns cold tumors to hot, a discovery that could lead to an immunotherapy to treat cancer. The study results were published December 30th in the Proceedings of the National Academy of Sciences. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 7, 2020 Category: Cancer & Oncology Source Type: news

Even a Single Dose of HPV Vaccine May Provide Protection
Young women who got only one dose of HPV vaccine, versus the recommended three, showed benefits against cancer-causing human papillomavirus. (Source: NYT Health)
Source: NYT Health - January 6, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Human Papillomavirus (HPV) Sexually Transmitted Diseases Vaccination and Immunization Source Type: news

Broadest ever therapeutic HPV vaccine to be tested in clinical trial
Treatment could clear up persistent infections and reduce risk of cervical cancerThe broadest vaccine yet that could clear up persistent HPV infections and reduce the risk of women developing cervical cancer is to be tested in a clinical trial.Human papillomavirus infections are common and are generally cleared by the body. However, about 10% of infections are not cleared, with persistent infections of certain types of HPV known to increase the risk of a number of cancers, including cervical cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 3, 2020 Category: Science Authors: Nicola Davis Tags: HPV vaccine Medical research Cervical cancer UK news Science Health Women Life and style Society Vaccines and immunisation World news Source Type: news

Just 1 dose of the HPV vaccine may protect against infection, new study suggests
A single dose of the human papillomavirus, or HPV, vaccine may be just as effective as two or three doses at preventing cancer-causing HPV infection, a new study suggests. (Source: CNN.com - Health)
Source: CNN.com - Health - December 28, 2019 Category: Consumer Health News Source Type: news